17 April 2021
Digital Event
Button

Sponsorship & Exhibition

Official Agency for AIFA Submissions (Pre-richiesta AIFA)

According to Italian legislation, any Marketing Authorisation Holder or pharmaceutical company responsible for the commercialisation of a drug, which organises or helps to organise, whether by direct or indirect funding in Italy or abroad, a congress, or a meeting on topics in any way related to the use of medicines in Italy, shall notify the competent Unit of the Italian Medicines Agency (AIFA) at least 60 days before the date of the event to ensure that these adhere to strict technical criteria and aim to provide further knowledge in the fields of chemistry, pharmaceutical technology, biochemistry, physiology, pathology and clinical medicine.

OIC S.r.l has been appointed as the official agency for AIFA submission to support sponsors and exhibitors with these formalities. Pharmaceutical companies which require the authorisation from AIFA are advised to contact OIC at email address: aifa-ecm-uems@oic.it before 1st February 2021:

OIC Srl
Viale Matteotti 7
50121 Firenze
Tel: 0039 055 50351
Email: AIFA-ECM-UEMS@oic.it “

Privacy Policy - disclaimer

EAACI recently updated its privacy policy and would like to highlight some key bits of information with you.

  • EAACI does not distribute, share or sell your information;
  • For technical and administrative purposes some information that can be used to identify you may be forwarded to third parties. For example, to process your registration for the EAACI Annual Congress and other EAACI events;
  • The Academy may also send you e-mail messages with news from the society. If you would like to no longer receive them, you can unsubscribe at any time by using the unsubscribe link in any of our communications;
  • You may also update your preferences or your profile information at any time by contacting us.

To continue please confirm that you agree with our updated privacy policy.

Thank you!

You have successfully agreed the new privacy policy – disclaimer.

Thank you!

You disagreed with the new privacy policy – disclaimer and your feedback will be reviewed as soon as possible.

Agree & Continue
Disagree
Send feedback
Cancel